A detailed history of Huntington National Bank transactions in Horizon Therapeutics Public LTD CO stock. As of the latest transaction made, Huntington National Bank holds 1 shares of HZNP stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$98.98 - $115.74 $12,768 - $14,930
-129 Reduced 99.23%
1 $0
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $4,527 - $5,281
-47 Reduced 26.55%
130 $13,000
Q1 2023

May 10, 2023

SELL
$107.32 - $113.5 $7,941 - $8,399
-74 Reduced 29.48%
177 $19,000
Q4 2022

Feb 09, 2023

SELL
$62.39 - $113.8 $13,476 - $24,580
-216 Reduced 46.25%
251 $28,000
Q3 2022

Nov 07, 2022

SELL
$58.92 - $84.67 $38,415 - $55,204
-652 Reduced 58.27%
467 $29,000
Q2 2022

Aug 09, 2022

BUY
$79.4 - $116.36 $555 - $814
7 Added 0.63%
1,119 $89,000
Q1 2022

May 10, 2022

BUY
$86.42 - $109.81 $2,246 - $2,855
26 Added 2.39%
1,112 $117,000
Q3 2021

Oct 28, 2021

BUY
$91.91 - $110.37 $46,230 - $55,516
503 Added 86.28%
1,086 $119,000
Q2 2021

Jul 30, 2021

BUY
$86.24 - $95.92 $19,404 - $21,582
225 Added 62.85%
583 $55,000
Q1 2021

Apr 12, 2021

SELL
$71.83 - $95.48 $933 - $1,241
-13 Reduced 3.5%
358 $33,000
Q4 2020

Jan 11, 2021

BUY
$67.0 - $84.39 $4,824 - $6,076
72 Added 24.08%
371 $27,000
Q3 2020

Oct 30, 2020

SELL
$55.23 - $79.93 $6,738 - $9,751
-122 Reduced 28.98%
299 $23,000
Q2 2020

Jul 30, 2020

SELL
$30.2 - $56.98 $346,333 - $653,446
-11,468 Reduced 96.46%
421 $23,000
Q1 2020

Apr 27, 2020

SELL
$24.87 - $38.56 $9,425 - $14,614
-379 Reduced 3.09%
11,889 $352,000
Q3 2019

Nov 01, 2019

SELL
$23.0 - $27.97 $62,284 - $75,742
-2,708 Reduced 18.08%
12,268 $334,000
Q2 2019

Jul 23, 2019

BUY
$22.81 - $28.48 $341,602 - $426,516
14,976 New
14,976 $360,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.